Good Lifestyle

Almost half of American adults have hypertension , more commonly called High blood pressure, according to centers for Disease Control and Prevention (CDC). Most of these patients are invited to to take pills , which can control blood pressure and prevent more serious complications such as heart disease and cerebral vascular accidents. If you are one of the many Americans who take these daily drugs (FDA). Read more to find out what experts recommend that you do if you have this prescription.

Read this then: Hypertension? Drinking 2 cups of coffee daily doubles cardiac disease risk of death, a new study reveals .

On December 21, the FDA announced that Lupine Pharmaceuticals voluntarily remembers four lots Quinapril tablets distributed to patients. The drug is an angiotensin conversion enzyme inhibitor (ACE), which reduces blood pressure in patients with hypertension. AE0FCC31AE342FD3A1346EBB1F342FCB

According to the opinion of the FDA, recent tests have revealed that the "presence of a nitrosamine impurity", called n-nitroso-quinapril, which was above the acceptable daily contribution (ADI). Affected terrain include both quinapril 20 mg USP tablets and Quinapril 40 mg USP tablets, which have been distributed in bottles of 90 accounts to "wholesalers, drug channels, correspondence pharmacies and supermarkets ».

The news comes after Aurobindo Pharma USA, Inc. voluntarily recalled two lots of Quinapril and Hydrochlorothiazide tablets due to same concern in October.

The FDA explains that nitrosamines are not always dangerous - everyone is exposed to a certain level of these compounds, because it is commonly found in "water and food, including dried and grilled meats, dairy products and vegetables ". But when people are exposed to higher levels of nitrosamines over long periods, the risk of cancer can increase.

The FDA has an entire page that gives an overview of Nitrosamines impurities in different drugs. According to the site, the FDA is actively studying the presence of these impurities and recommends that manufacturers recall drugs which can be superior to the ADI limits recognized internationally.

The agency explains that if your medication has nitrosamine levels inside or below the ADI limits and you take it every day for 70 years, you are not supposed to have an increased risk of cancer. The risk is only linked to those who acquire higher levels over longer periods.

To date, Lupine has not received any report of disease from the Quinapril tablets.

RELATED: For more up-to-date information, register for our daily newsletter .

The four batch of Quinapril recalled tablets were distributed between March 15, 2021 and September 1, 2022, while Lupine has stopped marketing the medication in September this year. The single batch of 20 mg tablets recalled at an expiration date of April 2023, a large number of G102929, a National Medicines Code (NDC) of 68180-558-09 (90), and a universal product code of 368180558095.

The remaining three lots contain tablets of 40 mg with an NDC of 68180-554-09 (90) and an UPC of 368180554097. The first two lots - G100533 and G100534 - both have an expiration date of December 2022 and The last lot of lot and the last batch —G203071 - has an expiration date of March 2023.

The UPCs are under the scanning barcode, and the NDCs are listed above the brand on the packaging. Lot numbers are printed on the side of the bottle label.

According to the FDA, Lupine currently calls all the entities where drugs have been distributed to inform them of the recall and organize a return of affected products. Meanwhile, those who have drugs in stock are invited to immediately cease to distribute reminded lots.

Consumers who take Quinapril 20 mg or 40 mg tablets are invited to contact their pharmacist, doctor or health care provider to find out an alternative treatment. In the meantime, continue to take your drugs as prescribed, says the FDA.

If you have any questions about the recall, you can contact Inmar RX Solutions, Inc. at (877) 538-8445, Monday to Friday between 9 a.m. and 5 p.m. Standard time of the East (East). If you are experiencing an unwanted reaction or encounter a quality problem associated with the use of the quinapril, the FDA asks you to report it to the reflective MEDWatch event reporting program. You can Do it online , or by ordinary or fax mail.

Best Life offers the most recent information from high -level experts, new research and health agencies, but our content is not supposed to replace professional advice. Regarding the medication you take or any other health issue you have, always consult your health care provider directly.